These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2339131)

  • 1. 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice.
    Zhou JY; Norman AW; Chen DL; Sun GW; Uskokovic M; Koeffler HP
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3929-32. PubMed ID: 2339131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
    Norman AW; Zhou JY; Henry HL; Uskokovic MR; Koeffler HP
    Cancer Res; 1990 Nov; 50(21):6857-64. PubMed ID: 2208153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships.
    Bischof MG; Redlich K; Schiller C; Chirayath MV; Uskokovic M; Peterlik M; Cross HS
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1254-60. PubMed ID: 8531089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
    Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
    J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of the cell differentiating agent 1alpha,25(OH)2-16-ene-23-yne vitamin D3 by leukemic cells.
    Satchell DP; Norman AW
    J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):117-24. PubMed ID: 8645610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1alpha,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells.
    Siu-Caldera ML; Clark JW; Santos-Moore A; Peleg S; Liu YY; Uskoković MR; Sharma S; Reddy GS
    J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):405-12. PubMed ID: 9010346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.
    Reddy GS; Rao DS; Siu-Caldera ML; Astecker N; Weiskopf A; Vouros P; Sasso GJ; Manchand PS; Uskokovic MR
    Arch Biochem Biophys; 2000 Nov; 383(2):197-205. PubMed ID: 11185554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
    Jung SJ; Lee YY; Pakkala S; de Vos S; Elstner E; Norman AW; Green J; Uskokovic M; Koeffler HP
    Leuk Res; 1994 Jun; 18(6):453-63. PubMed ID: 8207963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels.
    Pakkala S; de Vos S; Elstner E; Rude RK; Uskokovic M; Binderup L; Koeffler HP
    Leuk Res; 1995 Jan; 19(1):65-72. PubMed ID: 7837819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antileukemic effect of a synthetic vitamin D3 analog, HY-11, with low potential to cause hypercalcemia.
    Yoon JS; Kim JY; Park HK; Kim ES; Ahn KS; Yoon SS; Cho CG; Kim BK; Lee YY
    Int J Oncol; 2008 Feb; 32(2):387-96. PubMed ID: 18202761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivo.
    Schwartz GG; Hill CC; Oeler TA; Becich MJ; Bahnson RR
    Urology; 1995 Sep; 46(3):365-9. PubMed ID: 7660511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antineoplastic effect and toxicity of 1,25-dihydroxy-16-ene-23-yne-vitamin D3 in athymic mice with Y-79 human retinoblastoma tumors.
    Sabet SJ; Darjatmoko SR; Lindstrom MJ; Albert DM
    Arch Ophthalmol; 1999 Mar; 117(3):365-70. PubMed ID: 10088815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent antiproliferative effects of 25-hydroxy-16-ene-23-yne-vitamin D₃ that resists the catalytic activity of both CYP27B1 and CYP24A1.
    Rhieu SY; Annalora AJ; LaPorta E; Welsh J; Itoh T; Yamamoto K; Sakaki T; Chen TC; Uskokovic MR; Reddy GS
    J Cell Biochem; 2014 Aug; 115(8):1392-402. PubMed ID: 24535953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
    Hisatake J; Kubota T; Hisatake Y; Uskokovic M; Tomoyasu S; Koeffler HP
    Cancer Res; 1999 Aug; 59(16):4023-9. PubMed ID: 10463602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro effect of 1,25-dihydroxyvitamin D3 and 1,25-dihydroxy-16-ene-23-yne-vitamin D3 on the proliferation and differentiation of avian chondrocytes: their role in tibial dyschondroplasia.
    Farquharson C; Rennie JS; Loveridge N; Whitehead CC
    J Endocrinol; 1996 Mar; 148(3):465-74. PubMed ID: 8778225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3.
    Shabahang M; Buras RR; Davoodi F; Schumaker LM; Nauta RJ; Uskokovic MR; Brenner RV; Evans SR
    Cancer Res; 1994 Aug; 54(15):4057-64. PubMed ID: 8033137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization.
    Zhou JY; Norman AW; Lübbert M; Collins ED; Uskokovic MR; Koeffler HP
    Blood; 1989 Jul; 74(1):82-93. PubMed ID: 2665845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.